Skip to content

Achieva, Intera, Ingenia, Ingneia CX, Ingenia Elition, and Ingenia Ambition MR Systems

by Philips Medical Systems Nederland B.V.

510(k) K193215

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

100 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Abbreviated NumberK193215 Date10 Apr 2020ClearedStatusActive

Recalls

100 recalls · 100 ongoing · FDA

  • 3 recalls, same reason

    • Ongoing Z-3308-2026 FDA Class II initiated 28 Aug 2026
    • Ongoing Z-3311-2026 FDA Class II initiated 28 Aug 2026
    • Ongoing Z-3310-2026 FDA Class II initiated 28 Aug 2026

    When exporting diffusion tensor imaging (DTI) scans from a MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction with third-party software for tractography (e.g. for mapping nerve fiber pathways in the brain), the software will not be able to correctly process the DTI data for reconstruction.

  • 8 recalls, same reason

    • Ongoing Z-3239-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3238-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3243-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3241-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3237-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3233-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3236-2026 FDA Class II initiated 21 Aug 2026
    • Ongoing Z-3232-2026 FDA Class II initiated 21 Aug 2026

    A software issue will terminate an examination during the image reconstruction process if the scan parameters are manually adjusted such that reconstruction requirements exceed the available system memory.

  • 9 recalls, same reason

    • Ongoing Z-1965-2026 FDA Class II initiated 14 Apr 2026
    • Ongoing Z-1956-2026 FDA Class II initiated 14 Apr 2026
    • Ongoing Z-1951-2026 FDA Class II initiated 14 Apr 2026
    • Ongoing Z-1960-2026 FDA Class II initiated 14 Apr 2026
    • Ongoing Z-1954-2026 FDA Class II initiated 14 Apr 2026
    • Ongoing Z-1953-2026 FDA Class II initiated 14 Apr 2026
    • Ongoing Z-1967-2026 FDA Class II initiated 14 Apr 2026
    • Ongoing Z-1968-2026 FDA Class II initiated 14 Apr 2026
    • Ongoing Z-1961-2026 FDA Class II initiated 14 Apr 2026

    The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction voxel size settings in the default MRE scan protocol displaying too small.

  • 7 recalls, same reason

    • Ongoing Z-1207-2026 FDA Class II initiated 3 Dec 2025
    • Ongoing Z-1206-2026 FDA Class II initiated 3 Dec 2025
    • Ongoing Z-1209-2026 FDA Class II initiated 3 Dec 2025
    • Ongoing Z-1212-2026 FDA Class II initiated 3 Dec 2025
    • Ongoing Z-1211-2026 FDA Class II initiated 3 Dec 2025
    • Ongoing Z-1210-2026 FDA Class II initiated 3 Dec 2025
    • Ongoing Z-1208-2026 FDA Class II initiated 3 Dec 2025

    The potential for stiffness value errors when viewing exported MR Elastography (MRE) stiffness maps to viewer Picture Archiving and Communication System (PACS).

  • 11 recalls, same reason

    • Ongoing Z-2204-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2210-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2212-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2201-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2207-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2205-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2211-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2208-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2209-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2206-2025 FDA Class II initiated 30 Jun 2025
    • Ongoing Z-2200-2025 FDA Class II initiated 30 Jun 2025

    The potential for component failures in the Gradient Coil of the affected MR systems may act as a heat source with a potential to produce smoke and/or fire.

  • 8 recalls, same reason

    • Ongoing Z-1933-2025 FDA Class II initiated 29 May 2025
    • Ongoing Z-1930-2025 FDA Class II initiated 29 May 2025
    • Ongoing Z-1932-2025 FDA Class II initiated 29 May 2025
    • Ongoing Z-1928-2025 FDA Class II initiated 29 May 2025
    • Ongoing Z-1931-2025 FDA Class II initiated 29 May 2025
    • Ongoing Z-1929-2025 FDA Class II initiated 29 May 2025
    • Ongoing Z-1935-2025 FDA Class II initiated 29 May 2025
    • Ongoing Z-1934-2025 FDA Class II initiated 29 May 2025

    identified an issue where a component failure in the specific Gradient Coil type of affected systems can potentially act as a heat source, with a potential to produce smoke and/or fire. If smoke or a fire occurs, the risk to patients or operators may include inhalation of smoke, burns, and/or asphyxia which may lead to injury or even death. This issue could also lead to property damage.

  • 9 recalls, same reason

    • Ongoing Z-1800-2025 FDA Class II initiated 13 May 2025
    • Ongoing Z-1803-2025 FDA Class II initiated 13 May 2025
    • Ongoing Z-1798-2025 FDA Class II initiated 13 May 2025
    • Ongoing Z-1801-2025 FDA Class II initiated 13 May 2025
    • Ongoing Z-1799-2025 FDA Class II initiated 13 May 2025
    • Ongoing Z-1802-2025 FDA Class II initiated 13 May 2025
    • Ongoing Z-1795-2025 FDA Class II initiated 13 May 2025
    • Ongoing Z-1797-2025 FDA Class II initiated 13 May 2025
    • Ongoing Z-1796-2025 FDA Class II initiated 13 May 2025

    Potential for alignment errors in the cross reference line functionality when reviewing images generated with the MobiView application.

  • 14 recalls, same reason

    • Ongoing Z-1775-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1772-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1770-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1778-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1774-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1779-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1782-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1771-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1776-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1781-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1780-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1783-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1777-2025 FDA Class II initiated 24 Mar 2025
    • Ongoing Z-1773-2025 FDA Class II initiated 24 Mar 2025

    The Quadrature Body Coil (QBC) seal adhesive may fail, creating sharp edges that may come in contact with patients. If the QBC seal becomes loose during the scanning process, the risk to the patient may include skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.

  • 13 recalls, same reason

    • Ongoing Z-3204-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3193-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3198-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3199-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3205-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3202-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3196-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3200-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3203-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3194-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3201-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3195-2024 FDA Class II initiated 3 Sep 2024
    • Ongoing Z-3197-2024 FDA Class II initiated 3 Sep 2024

    Integrated Radio Frequency (IRF) Carrier assembly screws may come loose and protrude beyond the surface could cause the screws to interfere with other moving parts, potentially blocking the horizontal tabletop. May lead to delay in diagnosis and/or may include anxiety of a patient is left on the tabletop inside the bore for a longer duration than anticipated. movement.

  • 14 recalls, same reason

    • Ongoing Z-1853-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1839-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1850-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1849-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1847-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1852-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1845-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1838-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1848-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1836-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1842-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1851-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1837-2024 FDA Class II initiated 3 May 2024
    • Ongoing Z-1846-2024 FDA Class II initiated 3 May 2024

    The g-MDU (global Mains Distribution Unit) L3 terminal connection may become loose creating a hotspot that may cause smoke/fire to alarm in the hospital's technical room, resulting in Smoke and/or fire

  • 2 recalls, same reason

    • Ongoing Z-1830-2024 FDA Class II initiated 22 Apr 2024
    • Ongoing Z-1829-2024 FDA Class II initiated 22 Apr 2024

    Philips Ingenia Evolution systems with software R5.7.1 may not provide warning for low ventilation setting which may lead to increase in body temperature or burning sensation

  • 2 recalls, same reason

    • Ongoing Z-1583-2024 FDA Class II initiated 12 Mar 2024
    • Ongoing Z-1586-2024 FDA Class II initiated 12 Mar 2024

    Patient support table floor plate may be incorrectly installed.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LNH
Device Class
Class II
Regulation
21 CFR Part 892.1000
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Other devices from Philips Medical Systems Nederland B.V.

See all devices from Philips Medical Systems Nederland B.V. →